Zhang M, Wu C, Lu D, Wang X, Shang G
Sci China Life Sci. 2025; .
PMID: 39821837
DOI: 10.1007/s11427-024-2808-3.
Hobbs S, Nomburg J, Doudna J, Kranzusch P
Cell. 2024; 187(20):5530-5539.e8.
PMID: 39197447
PMC: 11455605.
DOI: 10.1016/j.cell.2024.07.057.
Yu X, Cai L, Yao J, Li C, Wang X
Molecules. 2024; 29(13).
PMID: 38999073
PMC: 11243509.
DOI: 10.3390/molecules29133121.
Tang Z, Zhao J, Li Y, Tomer S, Selvaraju M, Tien N
ACS Med Chem Lett. 2024; 15(5):653-658.
PMID: 38746895
PMC: 11089548.
DOI: 10.1021/acsmedchemlett.4c00048.
Lu Y, You L, Li L, Kilgore J, Liu S, Wang X
ACS Cent Sci. 2024; 9(12):2298-2305.
PMID: 38161369
PMC: 10755847.
DOI: 10.1021/acscentsci.3c01122.
At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment.
Korneenko T, Pestov N, Nevzorov I, Daks A, Trachuk K, Solopova O
Pharmaceuticals (Basel). 2023; 16(12).
PMID: 38139802
PMC: 10747911.
DOI: 10.3390/ph16121675.
The Many Ways to Deal with STING.
Coderch C, Arranz-Herrero J, Nistal-Villan E, de Pascual-Teresa B, Rius-Rocabert S
Int J Mol Sci. 2023; 24(10).
PMID: 37240378
PMC: 10219357.
DOI: 10.3390/ijms24109032.
10th anniversary of discovering cGAMP: synthesis and beyond.
Chen C
Org Chem Front. 2023; 10(4):1086-1098.
PMID: 37144138
PMC: 10153657.
DOI: 10.1039/d2qo02033e.
Potential Therapeutic Value of the STING Inhibitors.
Zhang S, Zheng R, Pan Y, Sun H
Molecules. 2023; 28(7).
PMID: 37049889
PMC: 10096477.
DOI: 10.3390/molecules28073127.
cGAMP-activated cGAS-STING signaling: its bacterial origins and evolutionary adaptation by metazoans.
Patel D, Yu Y, Xie W
Nat Struct Mol Biol. 2023; 30(3):245-260.
PMID: 36894694
PMC: 11749898.
DOI: 10.1038/s41594-023-00933-9.
Current understanding of the cGAS-STING signaling pathway: Structure, regulatory mechanisms, and related diseases.
Pan J, Fei C, Hu Y, Wu X, Nie L, Chen J
Zool Res. 2022; 44(1):183-218.
PMID: 36579404
PMC: 9841179.
DOI: 10.24272/j.issn.2095-8137.2022.464.
Activation of STING Based on Its Structural Features.
Hussain B, Xie Y, Jabeen U, Lu D, Yang B, Wu C
Front Immunol. 2022; 13:808607.
PMID: 35928815
PMC: 9343627.
DOI: 10.3389/fimmu.2022.808607.
Tembusu Virus Nonstructural Protein 2B Antagonizes Type I Interferon Production by Targeting MAVS for Degradation.
Zhou P, Li Y, Liu A, Zhang Q, Wu W, Jin H
J Virol. 2022; 96(14):e0081622.
PMID: 35867574
PMC: 9327690.
DOI: 10.1128/jvi.00816-22.
Phage anti-CBASS and anti-Pycsar nucleases subvert bacterial immunity.
Hobbs S, Wein T, Lu A, Morehouse B, Schnabel J, Leavitt A
Nature. 2022; 605(7910):522-526.
PMID: 35395152
PMC: 9117128.
DOI: 10.1038/s41586-022-04716-y.
Activation of STING by targeting a pocket in the transmembrane domain.
Lu D, Shang G, Li J, Lu Y, Bai X, Zhang X
Nature. 2022; 604(7906):557-562.
PMID: 35388221
PMC: 9098198.
DOI: 10.1038/s41586-022-04559-7.
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.
Garland K, Sheehy T, Wilson J
Chem Rev. 2022; 122(6):5977-6039.
PMID: 35107989
PMC: 8994686.
DOI: 10.1021/acs.chemrev.1c00750.
Polyvalent design in the cGAS-STING pathway.
Bennett Z, Li S, Sumer B, Gao J
Semin Immunol. 2021; 56:101580.
PMID: 34920941
PMC: 8792294.
DOI: 10.1016/j.smim.2021.101580.
A STING-based fluorescent polarization assay for monitoring activities of cyclic dinucleotide metabolizing enzymes.
Karanja C, Yeboah K, Ong W, Sintim H
RSC Chem Biol. 2021; 2(1):206-214.
PMID: 34458783
PMC: 8341399.
DOI: 10.1039/d0cb00187b.
Ligand Strain and Its Conformational Complexity Is a Major Factor in the Binding of Cyclic Dinucleotides to STING Protein.
Smola M, Gutten O, Dejmek M, Kozisek M, Evangelidis T, Aliakbar Tehrani Z
Angew Chem Int Ed Engl. 2021; 60(18):10172-10178.
PMID: 33616279
PMC: 8251555.
DOI: 10.1002/anie.202016805.
The BET family in immunity and disease.
Wang N, Wu R, Tang D, Kang R
Signal Transduct Target Ther. 2021; 6(1):23.
PMID: 33462181
PMC: 7813845.
DOI: 10.1038/s41392-020-00384-4.